China Health Industries Holdings, Inc.
CHHEDrugs in Pipeline
11
Phase 3 Programs
5
Upcoming Catalysts
1
Next Catalyst
Q1 2027
Market Overview
Stock performance and key metrics
1 upcoming, 0 past
Shenwu Capsule
Mild Cognitive Impairment
11-valent recombinant human papilloma virus vaccine (Hansenula polymorpha)
HPV InfectioN
Oxycodone/Naloxone
Cancer
2 doses of vaccine Quadrivalent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha)
Human Papillomavirus (HPV) Infection
IAH0968
Stomach Neoplasms
IBD0333
MTD
IAP0971
Advanced Malignant Neoplasm
MK-1045
Acute Lymphoblastic Leukemia
low-dose Recombinant SARS-CoV-2 Vaccine (CHO cell)
COVID-19
Romiplostim
Immune Thrombocytopenia (ITP)
IBB0979
Advanced Malignant Tumors
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Shenwu Capsule | Phase 3 | Mild Cognitive Impairment | - | - |
11-valent recombinant human papilloma virus vaccine (Hansenula polymorpha) | Phase 3 | HPV InfectioN | - | - |
Oxycodone/Naloxone | Phase 3 | Cancer | - | - |
2 doses of vaccine Quadrivalent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) | Phase 3 | Human Papillomavirus (HPV) Infection | - | - |
IAH0968 | Phase 3 | Stomach Neoplasms | - | - |
IBD0333 | Phase 2 | MTD | - | - |
IAP0971 | Phase 2 | Advanced Malignant Neoplasm | - | - |
MK-1045 | Phase 2 | Acute Lymphoblastic Leukemia | - | - |
low-dose Recombinant SARS-CoV-2 Vaccine (CHO cell) | Phase 2 | COVID-19 | - | - |
Romiplostim | Phase 2 | Immune Thrombocytopenia (ITP) | - | - |
IBB0979 | Phase 2 | Advanced Malignant Tumors | - | - |